Add BrightSurf on Google Email

Chinese Medical Journal review highlights new directions in pulmonary arterial hypertension

A new review highlights how molecular biology advances are reframing PAH as a complex vascular remodeling disease driven by endothelial dysfunction, chronic inflammation, metabolic dysregulation, and genetic susceptibility. Emerging therapies target the BMP/TGF-β pathway, growth factor signaling, and inflammatory pathways.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 11, 2026
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

New machine-learning tool improves accuracy of genomics research

Researchers have identified a widespread source of error in a popular genome study method and created a machine-learning tool to correct it. PATTY uses machine learning to reduce artifacts while preserving real signals in noisy data, giving researchers a clearer view of gene activity control.

SourceUniversity of Virginia Health System·DateJul 20, 2026

Thirty years later: A reappraisal of Alzheimer’s disease risk in Japanese APOE-e4 homozygotes

Researchers at Niigata University conducted the first comprehensive reappraisal of Alzheimer's disease risk in Japanese APOE-e4 homozygotes, finding a substantially lower risk than previously cited estimates. The study suggests that the risk is comparable to estimates reported in large studies of people with European ancestry.

SourceNiigata University·JournalMolecular Neurodegeneration·DateJun 29, 2026
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

UT MD Anderson shares latest research breakthroughs

Researchers at UT MD Anderson Cancer Center have made significant advances in understanding cancer biology, developing AI-powered atlas of tertiary lymphoid structures as prognostic biomarkers, and uncovering drivers of resistance to KRAS inhibitors. Additionally, they have discovered a molecular pathway that drives stressed cells to b...

SourceUniversity of Texas M. D. Anderson Cancer Center·DateJun 4, 2026

Predicting genetic risk for Type 1 diabetes just got more accurate thanks to UC San Diego study

The study demonstrates that the T1GRS tool can identify children and adults at high risk for Type 1 diabetes earlier than current methods, enabling preventive measures before the disease develops. The researchers grouped individuals into four sub-types based on genetic features, each with unique clinical profiles and outcomes.

SourceUniversity of California - San Diego·JournalNature Genetics·TypeComputational simulation/modeling·DateApr 30, 2026
GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.

Pharmacogenomics expert advances precision medicine for bipolar disorder

Dr. Mirko Manchia's groundbreaking research identifies genetic markers predicting treatment response in bipolar patients, enabling precision medicine approaches to transform psychiatric care. He envisions a future where genetic testing becomes routine in psychiatric care.

SourceGenomic Press·JournalGenomic Psychiatry·TypeNews article·DateJul 8, 2025

New gene therapy delivery device could let hospitals create personalized nanomedicines on-demand

A new gene therapy delivery device called NANOSPRESSO could revolutionize how hospitals treat rare diseases by allowing them to create personalized nanomedicines in-house. This democratized approach to precision medicine could boost access to low-cost bespoke gene and RNA therapies, especially in low-resource settings.

SourceFrontiers·JournalFrontiers in Science·TypeSystematic review·DateJun 26, 2025

New study reveals how 5'LysTTT tRNA fragments protect neurons during botulinum toxin exposure

Scientists have uncovered a previously unknown mechanism explaining how neurons survive botulinum neurotoxin type A exposure. The research found that specific tRNA fragments interact with key proteins and RNA molecules involved in regulating ferroptosis, supporting neuronal survival by blocking cell death pathways.

SourceGenomic Press·JournalGenomic Psychiatry·TypeExperimental study·DateMay 20, 2025
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Substance use accelerates brain aging through distinct molecular pathways, groundbreaking study reveals

Researchers identified unique biological mechanisms that cause premature aging in the brains of individuals with alcohol, opioid, and stimulant use disorders. Different substances appear to hijack the brain's natural aging rhythm through distinct molecular mechanisms, though some pathways are shared across different substance types.

SourceGenomic Press·JournalGenomic Psychiatry·TypeExperimental study·DateApr 29, 2025

Identifying a novel factor in Canavan disease pathogenesis

A new study reports on five patients with Canavan disease who have a novel variant identified through targeted long-read sequencing, revealing an SVA_E retrotransposable element that disrupts gene function. The findings enhance genetic diagnostics and enable improved guidance for families.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalHuman Gene Therapy·TypeExperimental study·DateApr 25, 2025
Sky & Telescope Pocket Sky Atlas, 2nd Edition

Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.

New study reveals potential link between GLP1 agonists and depression: Calls for urgent attention

A recent study published in Current Neuropharmacology suggests a potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists and depression, particularly in individuals with low dopamine function. The authors urge caution and recommend genetic testing to identify individuals at risk before prescribing these medications.

SourceBentham Science Publishers·JournalCurrent Neuropharmacology·DateApr 17, 2025

Largest ever genome-wide association study uncovers new drug targets and potential therapies for osteoarthritis

A recent study has made a breakthrough in understanding the genetic underpinnings of osteoarthritis by identifying 962 genetic markers associated with the condition. The researchers found 513 new genetic markers that were not previously reported, providing potential new drug targets and opportunities for repurposing existing medications.

SourceUniversity of Maryland School of Medicine·JournalNature·TypeMeta-analysis·DateApr 15, 2025
Sky-Watcher EQ6-R Pro Equatorial Mount

Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.

New key genes in Parkinson’s disease identified using CRISPR technology

Researchers used CRISPR interference to examine every gene in the human genome and discovered a new set of genes contributing to Parkinson's disease risk. The study identified the Commander complex, which regulates lysosomal function and is implicated in PD risk, offering opportunities for new treatments.

SourceNorthwestern University·JournalScience·DateApr 11, 2025

Genetic predisposition to sedentary behavior increases the risk of cardiovascular diseases

A new study found that genetic predisposition to sedentary behavior is associated with a higher risk of developing the most common cardiovascular diseases. Individuals with the highest genetic predisposition accumulated more daily sedentary time and had a 20% higher risk of cardiovascular diseases.

SourceUniversity of Jyväskylä - Jyväskylän yliopisto·JournalBritish Journal of Sports Medicine·DateApr 8, 2025

Recruiting now: Australian study to uncover genetic cause of rare diseases

A national study in Australia aims to understand the genetic cause of rare diseases, improving diagnoses and treatment options for those affected. The study is recruiting Australians with a known or suspected rare genetic disease to gather information and connect them with future research opportunities.

SourceGarvan Institute of Medical Research·TypeObservational study·DateApr 7, 2025
Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.

Breakthrough study sheds new light on causes of spina bifida and potential treatments

A new study published in Nature reveals critical insights into how spina bifida develops, identifying specific steps in embryogenesis that contribute to the condition. The research also suggests a potential link between new DNA mutations and disease risk, opening the door for future treatments such as gene therapy and targeted drugs.

SourceRady Children's Institute for Genomic Medicine·JournalNature·TypeExperimental study·DateApr 1, 2025

New study helps optimize gene therapy

A multidisciplinary team has generated an atlas to optimize gene therapy delivery, providing researchers with insights into the most effective viral vectors for specific tissues. The study identifies AAV4 as a promising vector for vascular and pancreatic applications, offering new possibilities for treating conditions like diabetes.

SourceBaylor College of Medicine·JournalMolecular Therapy·TypeExperimental study·DateApr 1, 2025
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

Study finds knowledge of genetics and genomic medicine crucial for mental health providers to deliver informed, personalized care

A new study emphasizes the importance of understanding genetic underpinnings of psychiatric disorders for mental health providers. Key findings highlight the application of genetic information in risk assessment, diagnosis, treatment selection, and patient education, while also considering ethical considerations.

SourceRady Children's Institute for Genomic Medicine·JournalAmerican Journal of Psychiatry·TypeSystematic review·DateMar 26, 2025

Genomic screening is important in identifying disease risk, study finds

A study published in JAMA Network Open found that more than 90% of participants with medically important genetic findings were unaware of their risk prior to participation in Geisinger's MyCode program. The initiative has disclosed genetic results to over 354,000 participants, who can now take proactive steps to prevent or detect disease.

SourceGeisinger Health System·JournalJAMA Network Open·DateMar 20, 2025
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Blood metabolites may reduce genetic risk of glaucoma

A study found that adding blood metabolite data to genetic risk scores improves glaucoma prediction accuracy, particularly in individuals at high genetic risk. Higher levels of lactate, pyruvate, and citrate were associated with a reduced risk of glaucoma.

SourceeLife·JournaleLife·DateMar 11, 2025

Genomics to revolutionize treatment of childhood rare diseases

A genomics blood test has improved diagnosis and treatment plans for children with rare diseases, including epilepsy. The test provides genetic diagnoses for 43% of children in under three weeks, leading to significant impacts on treatment.

SourceUniversity College London·Journalnpj Genomic Medicine·DateMar 6, 2025

Advanced genetic blueprint could unlock precision medicine

A comprehensive genetic representation for over 2.5 billion people has been created, capturing genetic diversity and variations found in diverse populations. This pangenome reference aims to enhance early diagnosis and personalized treatments for genetic diseases prevalent in the region.

SourceUniversity of Birmingham·JournalNature Medicine·TypeMeta-analysis·DateMar 4, 2025
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

Study uncovers genetic drivers of aggressive prostate cancer

A study uncovered new genetic clues explaining why some prostate cancers grow slowly while others become life-threatening, identifying 223 mutations that determine tumor progression. The research shows germline and somatic variability work together to initiate and drive prostate cancer.

SourceUniversity of California - Los Angeles Health Sciences·JournalCancer Discovery·DateMar 3, 2025

Genetic therapy gives infants life-changing improvements in sight

A new genetic medicine has been developed to treat a rare genetic deficiency affecting the AIPL1 gene, causing severe retinal dystrophy. The treatment involves injecting healthy copies of the gene into the retina through keyhole surgery, resulting in dramatic improvements in sight for four young children.

SourceUniversity College London·JournalThe Lancet·TypeExperimental study·DateFeb 20, 2025
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Activating complex regions of the genome to treat rare diseases

Scientists at Duke University have discovered a master epigenetic switch that can be activated using CRISPR to compensate for missing genes in Prader-Willi syndrome. This approach could potentially treat the disease by turning on naturally suppressed genes from one parent, addressing the underlying genetic defect.

SourceDuke University·JournalCell Genomics·TypeExperimental study·DateFeb 12, 2025

Researchers create genetic map tied to kidney disease

A new study from the University of Pennsylvania School of Medicine has created a comprehensive genetic map of over 1,000 genes influencing kidney function, providing new insights into the causes of kidney disease. The researchers discovered that proximal tubule cells are a key

SourceUniversity of Pennsylvania School of Medicine·JournalScience·DateFeb 11, 2025
Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

AI unlocks genetic clues to personalize cancer treatment

A groundbreaking study analyzed data from over 78,000 cancer patients to identify nearly 800 genetic changes impacting survival outcomes. The research also discovered genes significantly associated with survival in various cancers, such as breast, ovarian, skin, and gastrointestinal cancers.

SourceUniversity of Southern California·JournalNature Communications·DateFeb 11, 2025

Personalized cancer treatment using 3D bioprinting technology

A new 3D bioprinted gastric cancer model successfully replicates the unique characteristics of individual patients' tissues, predicting drug responses and prognosis with high accuracy. This innovative platform enables rapid evaluation within two weeks, contributing to personalized cancer treatment development.

SourcePohang University of Science & Technology (POSTECH)·JournalAdvanced Science·DateFeb 7, 2025
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

New light-tuned chemical tools control processes in living cells

Researchers at Umeå University have developed next-generation chemo-optogenetic tools that enable precise control of proteins in real-time in living cells. The new molecular glues can be turned on or off using light, allowing for multiple activation cycles and overcoming limitations of previous systems.

SourceUmea University·JournalAngewandte Chemie·TypeExperimental study·DateJan 30, 2025

Over 500 patients receive diagnosis through genetic reanalysis

A European consortium has successfully diagnosed over 500 patients with unknown conditions, including rare neurological disorders and hereditary cancers. The diagnoses were made possible by extensive collaboration and reanalysis of existing genome data.

SourceRadboud University Medical Center·JournalNature Medicine·TypeData/statistical analysis·DateJan 17, 2025

New insight: Scientists identify genes driving cancer spread

Researchers have identified a 177-gene signature common to metastasis across cancers, allowing for personalized risk assessment and potential therapies. The discovery could lead to broader treatment options, faster drug access, and improved patient outcomes.

SourceUniversity of Southern Denmark Faculty of Health Sciences·JournalMolecular Cancer·DateJan 9, 2025
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

A new era in genetic engineering

Researchers have developed a new genetic engineering tool, mvGPT, that can precisely edit genes, activate gene expression, and repress genes all at the same time. The technology has shown promise in treating genetic diseases such as Wilson's disease and type I diabetes by targeting multiple genetic conditions simultaneously.

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalNature Communications·TypeExperimental study·DateJan 8, 2025

New Reichman University study: Advances in cancer treatment and research: ChiTaRS 8.0 database of chimeric genes launched to facilitate the precise adaptation of treatments to specific cancer types

The ChiTaRS 8.0 database is the world's largest collection of chimeric genes found in humans with cancer and other chronic diseases. It enables the precise adaptation of treatments to specific cancer types, improving treatment success and minimizing side effects.

SourceReichman University·JournalNucleic Acids Research·TypeRandomized controlled/clinical trial·DateJan 1, 2025
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.